These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 30370905)
1. An oxaliplatin(iv) prodrug-based supramolecular self-delivery nanocarrier for targeted colorectal cancer treatment. Lim WQ; Phua SZF; Chen H; Zhao Y Chem Commun (Camb); 2018 Nov; 54(90):12762-12765. PubMed ID: 30370905 [TBL] [Abstract][Full Text] [Related]
2. Coordination-driven self-assembly of a Pt(iv) prodrug-conjugated supramolecular hexagon. Yue Z; Wang H; Li Y; Qin Y; Xu L; Bowers DJ; Gangoda M; Li X; Yang HB; Zheng YR Chem Commun (Camb); 2018 Jan; 54(7):731-734. PubMed ID: 29303526 [TBL] [Abstract][Full Text] [Related]
3. Cyclodextrin capped gold nanoparticles as a delivery vehicle for a prodrug of cisplatin. Shi Y; Goodisman J; Dabrowiak JC Inorg Chem; 2013 Aug; 52(16):9418-26. PubMed ID: 23889547 [TBL] [Abstract][Full Text] [Related]
4. Self-controlled release of Oxaliplatin prodrug from d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) functionalized mesoporous silica nanoparticles for cancer therapy. Liang C; Wang H; Zhang M; Cheng W; Li Z; Nie J; Liu G; Lian D; Xie Z; Huang L; Zeng X J Colloid Interface Sci; 2018 Sep; 525():1-10. PubMed ID: 29679795 [TBL] [Abstract][Full Text] [Related]
5. Platinum(iv) prodrugs with long lipid chains for drug delivery and overcoming cisplatin resistance. Chen Q; Yang Y; Lin X; Ma W; Chen G; Li W; Wang X; Yu Z Chem Commun (Camb); 2018 May; 54(42):5369-5372. PubMed ID: 29744485 [TBL] [Abstract][Full Text] [Related]
6. A cancer specific oxaliplatin-releasing Pt(iv)-prodrug. Reshetnikov V; Arkhypov A; Julakanti PR; Mokhir A Dalton Trans; 2018 May; 47(19):6679-6682. PubMed ID: 29708261 [TBL] [Abstract][Full Text] [Related]
8. Monochalcoplatin: An Actively Transported, Quickly Reducible, and Highly Potent Pt Ma L; Wang N; Ma R; Li C; Xu Z; Tse MK; Zhu G Angew Chem Int Ed Engl; 2018 Jul; 57(29):9098-9102. PubMed ID: 29806087 [TBL] [Abstract][Full Text] [Related]
9. A dual-targeting hybrid platinum(IV) prodrug for enhancing efficacy. Xiao H; Yan L; Zhang Y; Qi R; Li W; Wang R; Liu S; Huang Y; Li Y; Jing X Chem Commun (Camb); 2012 Nov; 48(87):10730-2. PubMed ID: 23012698 [TBL] [Abstract][Full Text] [Related]
10. Fine-Tuning the Linear Release Rate of Paclitaxel-Bearing Supramolecular Filament Hydrogels through Molecular Engineering. Chakroun RW; Wang F; Lin R; Wang Y; Su H; Pompa D; Cui H ACS Nano; 2019 Jul; 13(7):7780-7790. PubMed ID: 31117370 [TBL] [Abstract][Full Text] [Related]
11. Human Serum Albumin Conjugated Nanoparticles for pH and Redox-Responsive Delivery of a Prodrug of Cisplatin. Shi H; Cheng Q; Yuan S; Ding X; Liu Y Chemistry; 2015 Nov; 21(46):16547-54. PubMed ID: 26405808 [TBL] [Abstract][Full Text] [Related]
12. Near-infrared light-mediated photoactivation of a platinum antitumor prodrug and simultaneous cellular apoptosis imaging by upconversion-luminescent nanoparticles. Min Y; Li J; Liu F; Yeow EK; Xing B Angew Chem Int Ed Engl; 2014 Jan; 53(4):1012-6. PubMed ID: 24311528 [TBL] [Abstract][Full Text] [Related]
13. Hypoxia Active Platinum(IV) Prodrugs of Orotic Acid Selective to Liver Cancer Cells. Maji M; Bhattacharya I; Acharya S; Chakraborty MP; Gupta A; Mukherjee A Inorg Chem; 2021 Apr; 60(7):4342-4346. PubMed ID: 33711231 [TBL] [Abstract][Full Text] [Related]
14. The design and characterization of a novel beta-casein nano-vehicle loaded with platinum anticancer drug for drug delivery. Divsalar A; Razmi M; Saboury AA; Seyedarabi A Anticancer Agents Med Chem; 2014; 14(6):892-900. PubMed ID: 24521150 [TBL] [Abstract][Full Text] [Related]
15. Maleimide-functionalised platinum(IV) complexes as a synthetic platform for targeted drug delivery. Pichler V; Mayr J; Heffeter P; Dömötör O; Enyedy ÉA; Hermann G; Groza D; Köllensperger G; Galanksi M; Berger W; Keppler BK; Kowol CR Chem Commun (Camb); 2013 Mar; 49(22):2249-2251. PubMed ID: 23396381 [TBL] [Abstract][Full Text] [Related]
16. Engineering liposomal nanoparticles of cholesterol-tethered amphiphilic Pt(iv) prodrugs with prolonged circulation time in blood. Datta P; Bang S; Yue Z; Beach T; Stilgenbauer M; Wang H; Bowers DJ; Kurokawa M; Xiao H; Zheng YR Dalton Trans; 2020 Jun; 49(24):8107-8113. PubMed ID: 32490446 [TBL] [Abstract][Full Text] [Related]
17. Supramolecular hydrogels from cisplatin-loaded block copolymer nanoparticles and α-cyclodextrins with a stepwise delivery property. Zhu W; Li Y; Liu L; Chen Y; Wang C; Xi F Biomacromolecules; 2010 Nov; 11(11):3086-92. PubMed ID: 20958000 [TBL] [Abstract][Full Text] [Related]
18. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery. Xu Z; Wang D; Xu S; Liu X; Zhang X; Zhang H Chem Asian J; 2014 Jan; 9(1):199-205. PubMed ID: 24136878 [TBL] [Abstract][Full Text] [Related]
19. Efficient co-delivery of a Pt(IV) prodrug and a p53 activator to enhance the anticancer activity of cisplatin. Ma R; Wang Y; Yan L; Ma L; Wang Z; Chan HC; Chiu SK; Chen X; Zhu G Chem Commun (Camb); 2015 May; 51(37):7859-62. PubMed ID: 25854514 [TBL] [Abstract][Full Text] [Related]
20. Human transport protein carrier for controlled photoactivation of antitumor prodrug and real-time intracellular tumor imaging. Li X; Mu J; Liu F; Tan EW; Khezri B; Webster RD; Yeow EK; Xing B Bioconjug Chem; 2015 May; 26(5):955-61. PubMed ID: 25938732 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]